Encompass Health (EHC) director awarded 29 RSUs from dividend credit

Rhea-AI Filing Summary

Williams Terrance reported acquisition or exercise transactions in this Form 4 filing.

Encompass Health Corp director Terrance Williams received an automatic grant of 29 restricted stock units (RSUs) on July 15, 2026. The RSUs were credited as a dividend equivalent on existing awards, tied to a $0.19 per share common dividend and a $109.88 closing stock price, increasing his direct holdings to 16,859 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Williams Terrance

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	29	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 16,859 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 29 shares Dividend per share: $0.19 per share Closing stock price: $109.88 +1 more

4 metrics

RSUs granted 29 shares Grant of restricted stock units credited on July 15, 2026

Dividend per share $0.19 per share Common stock dividend paid on July 15, 2026

Closing stock price $109.88 Encompass Health closing price on the July 15, 2026 dividend payment date

Shares held after transaction 16,859 shares Direct Encompass Health common stock holdings after RSU dividend grant

Key Terms

restricted stock units, per share dividend, dividend payment date

3 terms

restricted stock units financial

"additional restricted stock units (RSUs) are credited to each non-employee director's account"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

per share dividend financial

"the per share dividend, divided by (b) the closing price on the dividend payment date"

dividend payment date financial

"On July 15, 2026, Encompass Health paid a dividend on its common stock"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/16/2026 - 04:20 PM Accepted by SEC EDGAR 07/16/2026 - 04:19 PM Learn about SEC filing dates

FAQ

What insider transaction did Encompass Health (EHC) report for Terrance Williams?

Encompass Health reported that director Terrance Williams received an automatic grant of 29 restricted stock units (RSUs) on July 15, 2026. The award is reflected as Encompass Health common stock, bringing his direct holdings to 16,859 shares after the transaction.

Why did Terrance Williams receive 29 RSUs from Encompass Health (EHC)?

The 29 RSUs were credited under non-employee director RSU agreements in connection with a common stock dividend. RSUs are added based on existing RSU balances, the $0.19 per share dividend, and the $109.88 closing price on the dividend payment date.

How many Encompass Health (EHC) shares does Terrance Williams hold after this grant?

Following the RSU dividend-equivalent grant, Terrance Williams directly holds 16,859 Encompass Health common shares. This figure reflects his position after the 29 RSUs associated with the July 15, 2026 dividend were added to his account.

What dividend and share price were used to calculate the RSU credit at Encompass Health (EHC)?

The RSU credit was based on a common stock dividend of $0.19 per share and a $109.88 Encompass Health closing stock price on July 15, 2026. These figures determine how many RSUs are added to each non-employee director’s account.

Is the Encompass Health (EHC) Form 4 for Terrance Williams a market purchase or sale?

No. The Form 4 shows a grant/award acquisition of 29 RSUs, not an open-market purchase or sale. The RSUs were automatically credited as a dividend-equivalent award linked to Encompass Health’s common stock dividend and closing share price.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Terrance

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM ALABAMA 35242

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	07/15/2026		A		29(1)	A	$0	16,859	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments, The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On July 15, 2026, Encompass Health paid a dividend on its common stock of $0.19 per share and the closing price was $109.88. The transaction reported on this Form 4 is an award of RSUs as sociated with that dividend payment.

	/s/ Patrick Darby, attorney-in-fact for Terrance Williams	07/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)